2019
DOI: 10.1111/bcp.14073
|View full text |Cite
|
Sign up to set email alerts
|

Drug‐induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis

Abstract: Aims Drug‐induced aseptic meningitis (DIAM) is an adverse drug reaction of exclusion; only few studies have addressed this iatrogenic disease. The aim was to characterize DIAM and to identify suspected drugs. Methods Data were collected from the analysis of the French Pharmacovigilance Database from inception (1 January 1985) to 8 March 2017. All cases were initially analysed according to the French imputability method by institutional pharmacologists (clinicians or pharmacists). Further analyses of well docum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
26
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 18 publications
0
26
0
Order By: Relevance
“…The pathogenic mechanism of NSAID-induced aseptic meningitis and meningism remain unclear. Some clinicians pro-posed that this adverse effect is consistent with the hypersensitivity [12] and meningeal irritation theory [2,9]. Initially, we had no clue whether it was a case of meningoencephalitis or drug-induced aseptic meningitis.…”
Section: Discussionmentioning
confidence: 80%
See 1 more Smart Citation
“…The pathogenic mechanism of NSAID-induced aseptic meningitis and meningism remain unclear. Some clinicians pro-posed that this adverse effect is consistent with the hypersensitivity [12] and meningeal irritation theory [2,9]. Initially, we had no clue whether it was a case of meningoencephalitis or drug-induced aseptic meningitis.…”
Section: Discussionmentioning
confidence: 80%
“…rheumatologic disorders, systemic lupus erythematous, and mixed connective tissue disorder [3,4,6]. French pharmacovigilance database on drug-induced aseptic meningitis [9] provided healthcare professionals with the list of drugs which were reported to have caused aseptic meningitis and the presenting signs and symptoms. Although many of the cases involved NSAIDs use in patients with underlying immunerelated disorders, this adverse event has also been reported, similar to our case, in previously healthy individuals [10,11].…”
Section: Discussionmentioning
confidence: 99%
“…HMGB1 (high-mobility group box 1), released or secreted by necrotic brain cells, may act as an early in ammation trigger inducing the local recruitment of pro-in ammatory cytokines, independently of BBB alterations. [6] An increase in the levels of neuronal speci c enolase, protein S100B, T-tau protein, neuro lament were also reported [6,31].Finally, CSF abnormalities can be induced by many factors including drugs, spinal cord compression, diabetes, and polyradiculoneuritis [32]. In uence of systemic and neuro in ammation after CA on CSF protein level could not be further explored because of the non-availability of albumin CSF/blood ratio or speci c MRI exploration to assess the BBB function [33,34].…”
Section: Discussionmentioning
confidence: 90%
“…The most commonly identified medication in DIAM is the nonsteroidal anti-inflammatory drugs (NSAIDs) with ibuprofen being the most likely observed NSAIDs among others. Other medications were observed including but not limited to intravenous immunoglobulin (IVIG), anticonvulsants, monoclonal antibodies, allopurinol, azathioprine, vaccines, and antimicrobial drugs [68].…”
Section: Discussionmentioning
confidence: 99%
“…Other infectious etiologies include mycobacterial, fungi, spirochetes, and parasites, and least possible etiologies are related to medications, malignancy, autoimmune disorder, and vaccines [2]. Drug-induced aseptic meningitis (DIAM) has been reported in the literature from different classes of medications [38]. Here, I report a case of recurrent DIAM related to TMP/SMX in a patient with no previous history of sulfamethoxazole allergy.…”
Section: Introductionmentioning
confidence: 99%